2017

1. Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection

   Clinical Microbiology and Infection, Vol. 23, Núm. 6, pp. 409.e5-409.e8